Zeria Pharmaceutical Co., Ltd. (4559.T)
JPY 2454.0
(1.95%)
JPY 2454.0
(1.95%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 40.46 Billion JPY | -0.02% |
| 2022 | 40.47 Billion JPY | 13.11% |
| 2021 | 35.78 Billion JPY | -1.13% |
| 2020 | 36.19 Billion JPY | -8.83% |
| 2019 | 39.69 Billion JPY | -1.58% |
| 2018 | 40.33 Billion JPY | -2.59% |
| 2017 | 41.4 Billion JPY | -1.77% |
| 2016 | 42.14 Billion JPY | 5.42% |
| 2015 | 39.98 Billion JPY | 0.31% |
| 2014 | 39.86 Billion JPY | 8.16% |
| 2013 | 36.85 Billion JPY | 18.44% |
| 2012 | 31.11 Billion JPY | 3.45% |
| 2011 | 30.07 Billion JPY | 8.35% |
| 2010 | 27.76 Billion JPY | 7.28% |
| 2009 | 25.87 Billion JPY | 7.43% |
| 2008 | 24.08 Billion JPY | -2.32% |
| 2007 | 24.66 Billion JPY | -2.1% |
| 2006 | 25.18 Billion JPY | -6.08% |
| 2005 | 26.81 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.68 Billion JPY | -14.53% |
| 2023 Q1 | 10.76 Billion JPY | -8.62% |
| 2023 FY | 40.46 Billion JPY | -0.02% |
| 2023 Q3 | 11.66 Billion JPY | 6.41% |
| 2023 Q2 | 10.95 Billion JPY | 1.84% |
| 2023 Q4 | 12.49 Billion JPY | 7.17% |
| 2022 Q3 | 10.25 Billion JPY | 6.12% |
| 2022 Q1 | 8.77 Billion JPY | -7.16% |
| 2022 FY | 40.47 Billion JPY | 13.11% |
| 2022 Q4 | 11.77 Billion JPY | 14.79% |
| 2022 Q2 | 9.66 Billion JPY | 10.14% |
| 2021 Q3 | 8.85 Billion JPY | -6.0% |
| 2021 FY | 35.78 Billion JPY | -1.13% |
| 2021 Q1 | 8.04 Billion JPY | -16.21% |
| 2021 Q2 | 9.42 Billion JPY | 17.11% |
| 2021 Q4 | 9.45 Billion JPY | 6.71% |
| 2020 Q3 | 9.03 Billion JPY | -1.42% |
| 2020 FY | 36.19 Billion JPY | -8.83% |
| 2020 Q1 | 8.39 Billion JPY | -11.99% |
| 2020 Q4 | 9.6 Billion JPY | 6.34% |
| 2020 Q2 | 9.16 Billion JPY | 9.09% |
| 2019 Q4 | 9.54 Billion JPY | -5.85% |
| 2019 Q3 | 10.13 Billion JPY | -3.58% |
| 2019 Q2 | 10.5 Billion JPY | 10.49% |
| 2019 FY | 39.69 Billion JPY | -1.58% |
| 2019 Q1 | 9.51 Billion JPY | -1.19% |
| 2018 FY | 40.33 Billion JPY | -2.59% |
| 2018 Q4 | 9.62 Billion JPY | -13.48% |
| 2018 Q3 | 11.12 Billion JPY | 7.75% |
| 2018 Q2 | 10.32 Billion JPY | 11.57% |
| 2018 Q1 | 9.25 Billion JPY | -11.49% |
| 2017 Q4 | 10.45 Billion JPY | 0.52% |
| 2017 FY | 41.4 Billion JPY | -1.77% |
| 2017 Q3 | 10.4 Billion JPY | 4.7% |
| 2017 Q2 | 9.93 Billion JPY | -6.37% |
| 2017 Q1 | 10.61 Billion JPY | 3.1% |
| 2016 Q2 | 9.81 Billion JPY | -6.38% |
| 2016 Q1 | 10.48 Billion JPY | 2.11% |
| 2016 Q4 | 10.29 Billion JPY | -10.97% |
| 2016 Q3 | 11.55 Billion JPY | 17.78% |
| 2016 FY | 42.14 Billion JPY | 5.42% |
| 2015 Q3 | 10.4 Billion JPY | 1.52% |
| 2015 Q1 | 9.06 Billion JPY | -20.21% |
| 2015 FY | 39.98 Billion JPY | 0.31% |
| 2015 Q4 | 10.26 Billion JPY | -1.32% |
| 2015 Q2 | 10.24 Billion JPY | 13.07% |
| 2014 FY | 39.86 Billion JPY | 8.16% |
| 2014 Q3 | 10.07 Billion JPY | 7.25% |
| 2014 Q2 | 9.39 Billion JPY | 3.87% |
| 2014 Q1 | 9.04 Billion JPY | -5.52% |
| 2014 Q4 | 11.35 Billion JPY | 12.79% |
| 2013 FY | 36.85 Billion JPY | 18.44% |
| 2013 Q4 | 9.56 Billion JPY | -4.71% |
| 2013 Q3 | 10.04 Billion JPY | 12.55% |
| 2013 Q2 | 8.92 Billion JPY | 7.2% |
| 2013 Q1 | 8.32 Billion JPY | 6.26% |
| 2012 Q3 | 8.38 Billion JPY | 11.06% |
| 2012 Q4 | 7.83 Billion JPY | -6.57% |
| 2012 Q2 | 7.54 Billion JPY | 2.63% |
| 2012 FY | 31.11 Billion JPY | 3.45% |
| 2012 Q1 | 7.35 Billion JPY | -5.23% |
| 2011 Q1 | 7.17 Billion JPY | 3.17% |
| 2011 FY | 30.07 Billion JPY | 8.35% |
| 2011 Q2 | 7.34 Billion JPY | 2.36% |
| 2011 Q3 | 7.79 Billion JPY | 6.03% |
| 2011 Q4 | 7.76 Billion JPY | -0.39% |
| 2010 Q1 | 6.65 Billion JPY | 0.61% |
| 2010 Q4 | 6.95 Billion JPY | -2.71% |
| 2010 Q2 | 7 Billion JPY | 5.26% |
| 2010 FY | 27.76 Billion JPY | 7.28% |
| 2010 Q3 | 7.15 Billion JPY | 2.13% |
| 2009 Q4 | 6.61 Billion JPY | -8.63% |
| 2009 Q3 | 7.23 Billion JPY | 20.56% |
| 2009 Q2 | 6 Billion JPY | -0.41% |
| 2009 Q1 | 6.02 Billion JPY | 3.37% |
| 2009 FY | 25.87 Billion JPY | 7.43% |
| 2008 Q2 | 6.02 Billion JPY | 0.0% |
| 2008 Q3 | 6.19 Billion JPY | 2.86% |
| 2008 FY | 24.08 Billion JPY | -2.32% |
| 2008 Q4 | 5.83 Billion JPY | -5.89% |
| 2007 FY | 24.66 Billion JPY | -2.1% |
| 2006 FY | 25.18 Billion JPY | -6.08% |
| 2005 FY | 26.81 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | 7.274% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 98.454% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 92.537% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 79.525% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -982.998% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 38.345% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -39.408% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 92.408% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -666.086% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 38.507% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | 12.541% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -250.253% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -391.553% |
| Tsumura & Co. | 48.8 Billion JPY | 17.081% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -21.428% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -107.118% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 36.512% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -219.702% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | 10.861% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -873.411% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -580.651% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -674.787% |
| MedRx Co., Ltd | 959 Million JPY | -4119.466% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -1308.09% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -2641.509% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -1606.891% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -67.452% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -14.201% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -5404.043% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 59.461% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -1692.624% |